scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(89)91143-4 |
P698 | PubMed publication ID | 2563048 |
P2093 | author name string | E C Benton | |
J A Hunter | |||
K Blessing | |||
K McLaren | |||
M H Bunney | |||
I W Smith | |||
B B Barr | |||
P2860 | cites work | Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 |
Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis | Q36285689 | ||
Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis | Q36863075 | ||
Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomavirus 3a, 8, 10, and 12 genomes | Q36909322 | ||
Cancer, warts, and sunshine in renal transplant patients. A case-control study | Q38918754 | ||
Immunology and photocarcinogenesis. New light on an old problem | Q39477739 | ||
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from upper-volta | Q43937425 | ||
Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. | Q53541015 | ||
Viral infections in renal allograft recipients treated with long-term immunosuppression | Q55603128 | ||
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs | Q55652491 | ||
Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes | Q59058210 | ||
Squamous cell carcinoma of the skin and lip in renal homograft recipients | Q67474923 | ||
Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial | Q69904848 | ||
Papillomavirus DNA in warts of immunosuppressed renal allograft recipients | Q70143566 | ||
Human papillomavirus infections in a group of renal transplant recipients | Q70160345 | ||
Human papillomavirus heterogeneity in 36 renal transplant recipients | Q70164506 | ||
Premalignant and malignant skin lesions in renal transplant patients | Q70318510 | ||
Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient | Q72558404 | ||
A Potentially Oncogenic Human Papillomavirus (HPV-5) Found in Two Renal Allograft Recipients | Q72869049 | ||
P433 | issue | 8630 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | skin cancer | Q192102 |
human papilloma virus | Q69999790 | ||
P304 | page(s) | 124-129 | |
P577 | publication date | 1989-01-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Human papilloma virus infection and skin cancer in renal allograft recipients | |
P478 | volume | 1 |
Q36318570 | A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. |
Q42454285 | A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients |
Q41886417 | Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients |
Q42471964 | Awareness of skin cancer by kidney transplant patients |
Q36450326 | Benign human papillomavirus infection in renal transplant recipients |
Q36671140 | Cancer risk following organ transplantation: a nationwide cohort study in Sweden |
Q42452841 | Carcinoma of the lip in kidney transplant recipients |
Q44839585 | Clinical Manifestations of Human Papillomavirus Infection in Nongenital Sites |
Q42481780 | Cutaneous malignancies in renal transplant recipients from Nova Scotia, Canada |
Q68250434 | Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: A clinical and molecular biological study |
Q72284400 | Cutaneous warts and tumours in immunosuppressed patients |
Q34283563 | Detection and typing of human papillomavirus in cutaneous warts of patients infected with human immunodeficiency virus type 1. |
Q45416672 | Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin |
Q72166392 | Development of multiple cutaneous squamous cell carcinomas during PUVA treatment for chronic graft-versus-host disease |
Q41129874 | Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures |
Q57922398 | Epidemiology and biology of cutaneous human papillomavirus |
Q40411088 | Epidemiology of human papillomaviruses. |
Q33494404 | Epidermodysplasia verruciformis and malignant thymoma |
Q46857684 | Epidermodysplasia verruciformis in Africans |
Q43511567 | Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease |
Q41561121 | Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression |
Q37141662 | Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis |
Q33297791 | Genitoanal papillomavirus infection: diagnostic and therapeutic objectives in the light of current epidemiological observations |
Q36043918 | HIV-related infections of the oral cavity |
Q77859950 | HLA and susceptibility to cervical neoplasia |
Q42509988 | HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer |
Q41561185 | HPV infections and immunosuppression |
Q35899890 | Health related quality of life in patients with actinic keratosis--an observational study of patients treated in dermatology specialist care in Denmark |
Q36831751 | Heterogeneity of the human papillomavirus group. |
Q42482331 | High Frequency of Detection of Epidermodysplasia Verruciformis–Associated Human Papillomavirus DNA in Biopsies from Malignant and Premalignant Skin Lesions from Renal Transplant Recipients |
Q42501628 | High rejection score in the first year and risk of skin cancer in heart transplantation. |
Q41084140 | Human Papillomavirus (HPV) Types Specific of Epidermodysplasia Verruciformis Detected in Warts Induced by HPV3 or HPV3-Related Types in Immunosuppressed Patients |
Q40921386 | Human papillomavirus detected in viral warts of renal transplant recipients |
Q77356984 | Human papillomavirus infections in skin cancers |
Q41467144 | Human papillomavirus-associated tumors of the skin and mucosa |
Q34743451 | Human papillomavirus: a review |
Q41485252 | Human papillomaviruses: general features |
Q35943114 | Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients |
Q42496342 | Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA. |
Q37143740 | In situ hybridisation in perspective |
Q42478812 | Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. |
Q42492822 | Incidence of skin cancer in 5356 patients following organ transplantation |
Q41251100 | Kaposi's sarcoma: evaluation of the role of human papillomaviruses. A study using the high sensitivity hot-start polymerase chain reaction detection method and a review of the literature |
Q40489237 | Keratinocyte Alterations in Skin Tumour Development |
Q41931217 | Low frequency of allelic loss in skin tumours from immunosuppressed individuals |
Q36473470 | Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia |
Q57008614 | Meeting report. Report of meeting of Section of Clinical Immunology and Allergy, 11 March 1991 |
Q36158929 | Molecular aetiology and pathogenesis of basal cell carcinoma |
Q42477310 | Muco-cutaneous manifestations in 178 renal transplant recipients |
Q36225611 | Multiple Skin Cancers in a Renal Transplant Recipient: A Patient Report with Analyses of Human Papillomavirus and Human Polyomavirus Infection |
Q40007123 | Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients |
Q35850054 | Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center |
Q42462754 | On a Possible Protective Effect of HLA-A11 Against Skin Cancer and Keratotic Skin Lesions in Renal Transplant Recipients |
Q38208275 | Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases |
Q41557437 | Oral lesions in organ transplant patients |
Q41485259 | Papillomavirus and HPV typing |
Q44111480 | Papillomavirus infection and skin cancer in renal allograft recipients |
Q41033568 | Premalignant keratinocytic neoplasms |
Q50543183 | Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study. |
Q35977611 | Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion |
Q36340146 | Primary malignant tumors of the nail unit |
Q46157177 | Recognition and management of high-risk cutaneous tumors |
Q36116199 | Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy |
Q36000874 | Renal transplantation, immunosuppression and the skin: an update |
Q53655820 | Resurfacing the back of the hand as treatment and prevention of multiple skin cancers in kidney transplant recipients. |
Q37995108 | Review: antibodies to cutaneous human papillomaviruses. |
Q41561128 | Role of HPV in cutaneous premalignant and malignant tumors |
Q40936277 | Roots and perspectives of contemporary papillomavirus research |
Q67486569 | Seroreactivity Against HPV 16 E4 and E7 Proteins in Renal Transplant Recipients and Pregnant Women |
Q42479938 | Skin Cancer and Warts in Immunosuppressed Renal Transplant Recipients |
Q63369190 | Skin cancer in heart transplant recipients: frequency and risk factor analysis |
Q74455780 | Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens |
Q38889549 | Skin infections in Egyptian renal transplant recipients |
Q42493820 | Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients |
Q42505303 | Southern blot analysis of skin biopsies for human papillomavirus DNA: renal allograft recipients in south-eastern Queensland |
Q73339580 | Squamous cell carcinoma of the lower lip in renal-transplant recipients. Report of six cases |
Q74595933 | Subungual squamous cell carcinoma in Darier's disease |
Q53288833 | Summary of inaugural meeting of the Skin Care in Organ Recipients Group, UK, held at the Royal Society of Medicine, 7 October 2004. |
Q42504365 | Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients |
Q38948602 | The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha |
Q37902633 | The cellular immune response to human papillomavirus infection |
Q40661257 | The effects of ultraviolet light irradiation on viral infections |
Q37975593 | The management of transitional cell carcinoma (TCC) in a European regional renal transplant population |
Q36465233 | The role of human papillomavirus in carcinoma |
Q24527224 | The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses |
Q36711033 | Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. |
Q47840579 | Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis |
Q36899164 | Urological malignancy after renal transplantation |
Q33532192 | [Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management]. |
Q41084094 | c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions |
Search more.